Fairmount Funds Management LLC's Net Worth
$59.9 Million
Who is Fairmount Funds Management LLC?
Fairmount Funds Management LLC has an estimated net worth of $59.9 Million. This is based on reported shares across multiple companies, which include Apogee Therapeutics, Inc., Viridian Therapeutics, Inc.\DE, Cogent Biosciences, Inc., Spyre Therapeutics, Inc., and Dianthus Therapeutics, Inc. /DE/.
SEC CIK
Fairmount Funds Management LLC's CIK is 0001802528
Past Insider Trading and Trends
2020 was Fairmount Funds Management LLC's most active year for acquiring shares with 12 total transactions. Fairmount Funds Management LLC's most active month to acquire stocks was the month of August. 2023 was Fairmount Funds Management LLC's most active year for disposing of shares, totalling 1 transactions. Fairmount Funds Management LLC's most active month to dispose stocks was the month of December. 2023 saw Fairmount Funds Management LLC paying a total of $60,998,761.21 for 4,416,034 shares, this is the most they've acquired in one year. In 2024 Fairmount Funds Management LLC cashed out on 892,529 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Apogee Therapeutics, Inc. (APGE) Snapshot price: $35.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
| 2.05M |
Mar 28
| |||
Form 4
| -88.53% | -790.20K |
—
|
—
| 102.33K |
Scheduled
|
Jan 29
| ||
Form 4
|
∞
| 2.94M |
$17.00 | $49,999,992.00 | 2.94M |
Jul 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Spyre Therapeutics, Inc. (AGLE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +961.81% | 3.64M |
—
|
—
| 4.02M |
Apr 25
| |||
Form 4
| -76.36% | -2.62M |
—
|
—
| 812.08K |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
∞
| 3.44M |
—
|
—
| 3.44M |
Nov 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dianthus Therapeutics, Inc. /DE/ (DNTH) Snapshot price: $23.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
| 2.7M |
Apr 1
| |||
Form 4
| +43.26% | 834.33K |
$12.00 | $10,012,008.00 | 2.76M |
Jan 22
| |||
Form 4
| +1.30% | 24.67K |
$13.63 | $336,252.10 | 1.93M |
Sep 29
| |||
Form 4
| +1.60% | 30K |
$13.15 | $394,500.00 | 1.9M |
Sep 26
| |||
Form 4
| +1.63% | 30K |
$13.20 | $396,000.00 | 1.87M |
Sep 19
| |||
Form 4
| +1.33% | 24.25K |
$11.20 | $271,679.87 | 1.84M |
Sep 11 - Sep 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Viridian Therapeutics, Inc.\DE (VRDN) Snapshot price: $17.735
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
| 1.85M |
Mar 28
| |||
Form 4
| +34.92% | 476.19K |
$21.00 | $9,999,990.00 | 1.84M |
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 4
| +45.35% | 425.53K |
$23.50 | $9,999,978.50 | 1.36M |
Aug 17
| |||
Form 4
| +3,109.50% | 909K |
$11.00 | $9,999,000.00 | 938.23K |
Sep 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 526.39K |
—
|
—
| 526.39K |
Oct 27
| |||
| No matching records found | |||||||||
Cogent Biosciences, Inc. (COGT) Snapshot price: $5.875
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
| 4.73M |
Mar 28
| |||
Form 4
| +35.65% | 1.17M |
$7.50 | $8,749,995.00 | 4.44M |
Feb 16
| |||
Form 4
| +32.36% | 800K |
$12.00 | $9,600,000.00 | 3.27M |
Jun 9
| |||
Form 4
| +94.33% | 1.2M |
$8.25 | $9,900,000.00 | 2.47M |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 9
| |||
Form 4
|
∞
| 6.24M |
—
|
—
| 6.24M |
Jul 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||